Roger D Kamm Selected Research

Lab-On-A-Chip Devices

1/2022	A predictive microfluidic model of human glioblastoma to assess trafficking of blood-brain barrier-penetrant nanoparticles.
3/2020	Microfluidic platform for three-dimensional cell culture under spatiotemporal heterogeneity of oxygen tension.
7/2018	In vitro models of molecular and nano-particle transport across the blood-brain barrier.
1/2018	In Vitro Microfluidic Models for Neurodegenerative Disorders.
1/2018	Studying TCR T cell anti-tumor activity in a microfluidic intrahepatic tumor model.
6/2017	A 3D microfluidic model for preclinical evaluation of TCR-engineered T cells against solid tumors.
1/2017	Endothelial monolayer permeability under controlled oxygen tension.
1/2016	Engineering a 3D microfluidic culture platform for tumor-treating field application.
11/2012	A novel microfluidic platform for high-resolution imaging of a three-dimensional cell culture under a controlled hypoxic environment.
2/2011	A high-throughput microfluidic assay to study neurite response to growth factor gradients.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Roger D Kamm Research Topics

Disease

43	Neoplasms (Cancer) 01/2022 - 02/2011
7	Neoplasm Metastasis (Metastasis) 01/2021 - 10/2013
7	Breast Neoplasms (Breast Cancer) 03/2020 - 11/2012
5	Hypoxia (Hypoxemia) 03/2020 - 11/2012
5	Neurodegenerative Diseases (Neurodegenerative Disease) 11/2019 - 08/2004
4	Rupture 10/2016 - 07/2008
3	Carcinoma (Carcinomatosis) 11/2015 - 07/2006
2	Nervous System Diseases (Neurological Disorders) 01/2022 - 07/2018
2	Neuromuscular Diseases (Neuromuscular Disease) 01/2020 - 01/2019
2	Fibrosarcoma 08/2012 - 07/2006
2	Myocardial Infarction 05/2006 - 11/2004
1	Glioma (Gliomas) 01/2022
1	Ischemia 01/2022
1	Glioblastoma (Glioblastoma Multiforme) 01/2022
1	Cardiovascular Diseases (Cardiovascular Disease) 01/2022
1	Brain Neoplasms (Brain Tumor) 01/2022
1	Vascular Remodeling 12/2020
1	Bites and Stings (Sting) 01/2020
1	Lung Neoplasms (Lung Cancer) 01/2020
1	Corneal Diseases (Corneal Disease) 09/2018
1	Carcinogenesis 09/2018
1	Cognitive Dysfunction 01/2018
1	Pancreatic Neoplasms (Pancreatic Cancer) 01/2018
1	Alzheimer Disease (Alzheimer's Disease) 01/2018
1	AIDS-Related Complex (ARC) 01/2017
1	Neoplasm Micrometastasis 03/2014
1	Adenocarcinoma of Lung 02/2013

Drug/Important Bio-Agent (IBA)

12	Pharmaceutical PreparationsIBA 01/2022 - 02/2013
6	Oxygen (Dioxygen)IBA 01/2022 - 01/2015
5	CollagenIBA 01/2021 - 03/2014
5	HydrogelsIBA 09/2016 - 01/2013
4	Matrix Metalloproteinases (MMPs)IBA 12/2020 - 07/2006
4	IntegrinsIBA 01/2018 - 11/2012
3	CytokinesIBA 10/2018 - 06/2017
2	FilaminsIBA 01/2022 - 07/2008
2	ActininIBA 01/2022 - 07/2008
2	ChemokinesIBA 01/2021 - 10/2018
2	LigandsIBA 01/2021 - 11/2012
2	Intercellular Adhesion Molecule-1 (Intercellular Adhesion Molecule 1)IBA 01/2020 - 09/2015
2	cadherin 5IBA 01/2019 - 01/2017
2	Peptides (Polypeptides)IBA 01/2018 - 05/2006
2	Epidermal Growth Factor (EGF)IBA 05/2017 - 09/2016
2	Dextrans (Dextran)FDA Link 01/2017 - 01/2013
1	fascinIBA 01/2022
1	Biocompatible Materials (Biomaterials)IBA 01/2022
1	Adenosine Triphosphate (ATP)IBA 01/2022
1	Hyaluronic Acid (Hyaluronan)IBA 01/2021
1	Glycoproteins (Glycoprotein)IBA 01/2021
1	Phenobarbital (Luminal)FDA Link 01/2021
1	CC ChemokinesIBA 01/2021
1	CathepsinsIBA 12/2020
1	Cysteine (L-Cysteine)FDA Link 12/2020
1	Peptide Hydrolases (Proteases)FDA Link 12/2020
1	Paclitaxel (Taxol)FDA LinkGeneric 11/2020
1	Collagen Type I (Type I Collagen)IBA 03/2020
1	Vascular Cell Adhesion Molecule-1 (Vascular Cell Adhesion Molecule 1)IBA 01/2020
1	cyclic guanosine monophosphate-adenosine monophosphateIBA 01/2020
1	Chemotactic FactorsIBA 01/2020
1	InterferonsIBA 01/2020
1	E-SelectinIBA 01/2020
1	MicroRNAs (MicroRNA)IBA 11/2019
1	Small Interfering RNA (siRNA)IBA 12/2018
1	Immune Checkpoint InhibitorsIBA 10/2018
1	RNA (Ribonucleic Acid)IBA 10/2018
1	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 10/2018
1	Biological ProductsIBA 02/2018
1	AntibodiesIBA 01/2018
1	Interleukin-8 (Interleukin 8)IBA 01/2018
1	Amyloid beta-PeptidesIBA 01/2018
1	podocalyxinIBA 01/2018
1	ezrinIBA 01/2018
1	DisintegrinsIBA 01/2018
1	Metalloproteases (Metalloproteinases)IBA 01/2018
1	Membrane Proteins (Integral Membrane Proteins)IBA 01/2018
1	T-Cell Antigen Receptors (T-Cell Receptor)IBA 06/2017
1	ActomyosinIBA 01/2017
1	PlasticsIBA 10/2016
1	Conditioned Culture MediaIBA 08/2016
1	Adenosine (Adenocard)FDA LinkGeneric 01/2015
1	Purinergic P1 Receptors (Adenosine Receptor)IBA 01/2015
1	Cytochalasin DIBA 11/2014
1	Interleukin-8B ReceptorsIBA 03/2014
1	Chemokine CXCL5IBA 03/2014
1	Ciclopirox (Loprox)FDA LinkGeneric 12/2013
1	Prolyl-Hydroxylase InhibitorsIBA 12/2013
1	LysophospholipidsIBA 12/2013
1	sphingosine 1-phosphate (sphingosine-1-phosphate)IBA 12/2013
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 08/2012
1	Actins (F Actin)IBA 07/2010
1	Microfilament Proteins (Actin Binding Proteins)IBA 07/2008
1	matrigelIBA 07/2006
1	Matrix Metalloproteinase InhibitorsIBA 07/2006
1	Fibronectins (Fibronectin)IBA 07/2006

Therapy/Procedure

17	Therapeutics 01/2022 - 02/2013
10	Lab-On-A-Chip Devices 01/2022 - 02/2011
6	Immunotherapy 01/2021 - 09/2015
2	Transplantation 01/2022 - 08/2013
2	Precision Medicine 01/2020 - 01/2015
1	Drug Therapy (Chemotherapy) 01/2016
1	Electrodes (Electrode) 01/2016